Complementary and Alternative Medicine Market By Type (Medicines, Therapy), By Disease Indication (Diabetes, Cardiovascular, Neurology, Cancer, Arthritis, Others), By Distribution Channels (Direct Sales, Online Sales, Distance Correspondence): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global complementary and alternative medicine market was valued at $101,995.95 million in 2021 and is projected to reach $437,864.92 million by 2031, registering a CAGR of 15.6% from 2022 to 2031 The term complementary and alternative medicines are used for those medicines which are not part of standard medical care. It can be used for various diseases such as cancer and chronic diseases. People with cancer can use complementary and alternative medicine (CAM) for various purposes such as it helps in coping up with the side effects of cancer treatment such as nausea, pain, and fatigue. Also, such therapies help cancer patients to reduce treatment-related stress and comfort themselves.
Some of the various types of complementary and alternative medicines are mind-body therapies which further include meditation, biofeedback, hypnosis, yoga, tai-chi, imagery, and various others. The biologically based CAM which are most commonly available includes vitamins, dietary supplements, botanicals (such as turmeric and cinnamon), and special diets and food. Energy healing CAM procedure involves reiki and therapeutic touch. And some other types of CAM procedures involve massage therapy, chiropractic therapy, and reflexology.
The key factors that drive the growth of the market are the rising prevalence of chronic and cancer disease, rise in the geriatric population, change in lifestyle, and an increase in adoption of natural ingredients such as herbs, food supplements, and ayurvedic formulations as alternative medicine and therapy. According to the World Health Organization report it has been estimated that around 80 % of individuals utilize herbal medication globally. Additionally, Ayurveda medicine has grown significantly in popularity during the pandemic as people turned to herbal or ayurvedic remedies to increase body immunity. Moreover, ayurvedic preventive, therapeutic, and convalescent care efforts for the COVID-19 pandemic were also expanded through the establishment of 1206 Ayur Raksha Clinics and accompanying task forces by the Kerala government in India in April 2020.
Moreover, the increase in the number of yoga and meditation centers in the last several years are also contributing in the growth of the complementary and alternative medicine market. For instance, post-COVID-19 pandemic there’s a huge increase in demand of yoga and meditation centers to keep mind & body relax, stress has been linked to the strengthening or weakening of the immune cells.
However, patients’ self-medication without consulting to physicians, and the high cost of various therapies hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity during the forecast period.
The complementary and alternative medicine market is segmented on the basis of type, disease indication, distribution channel, and region. By type, the market is segmented into medicine and therapies. On the basis of disease indication, the market is segmented into diabetes, cardiovascular, neurological, cancer, arthritis and others. By distribution channel, the market is segmented into a direct sale, online sales and distance correspondence. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type, on the basis of medicine, the market is further sub-segmented into ayurvedic, dietary supplements, homeopathic, traditional Chinese medicine, traditional Korean medicine, and others. On the basis of therapy, complementary and alternative medicine is further bifurcated into mind therapy, body therapy, magnetic therapy, and sensory therapy.
Furthermore, mind therapy is divided into autosuggestion, hypnotherapy, neuro-linguistic programming, self-hypnosis, spiritual mind treatment, and transcendental meditation. The body therapy is sub-segmented into acupressure, acupuncture, yoga, alexander technique, auriculotherapy, autogenic training, cupping therapy, osteopathy, and others. Magnetic therapy is bifurcated into bio-magnetic therapy and magnetic resonance therapy. And sensory therapy is further categorized into aroma therapy, music therapy, sonopuncture, and sound therapy.
North America accounted for a majority of the complementary and alternative medicine market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the increase in the healthcare expenditure of this region and the presence of major players in the country and the strategies they adopt for their product development.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in the prevalence of chronic diseases and the increase in the geriatric population.
The key players that operate in the complementary and alternative medicine market are All and one Medical, AYUSH Ayurvedic Pte Ltd., Douglas Laboratories, Herbal Hills, Herb Pharm LLC, John Schumacher Unity Woods Yoga Center, Juvenon LLC, New Life Chiropractic, Nordic Naturals, Nordic Nutraceuticals, Pure Encapsulations LLC, Quality of Life Labs, Ramamani Iyengar Memorial Yoga Institute, Sheng Chang Pharmaceutical Company, The Chicago Body Works, The Nature’s Bounty Co, Valensa Inernational
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the complementary and alternative medicine market analysis from 2021 to 2031 to identify the prevailing complementary and alternative medicine market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the complementary and alternative medicine market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global complementary and alternative medicine market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Medicines
Type
Ayurvedic Medicines
Dieatry Supplements
Homeopathic Medicines
Traditional Chinese Medicine
Traditional Korean Medicine
Others
Therapy
Type
Mind Therapy
Body Therapy
Sensory Therapy
Magnetic Therapy
By Disease Indication
Cancer
Arthritis
Others
Diabetes
Cardiovascular
Neurology
By Distribution Channels
Direct Sales
Online Sales
Distance Correspondence
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Columbia Nutritional
Herb Pharm
Herbal Hills
Helio USA Inc.
NatureKue
Nordic Nutraceuticals
Pure encapsulations, LLC.
The Healing Company Ltd.
AYUSH Ayurvedic Pte Ltd.
Sheng Chang Pharmaceutical Company
Bikram Yoga
Amrita Ayurveda and Yoga
Body and Soul Yoga Club
ALCES LLP
Yoga Tree Studios, Inc.
LKK Health Products Group Limited
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Medicines
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Medicines Complementary and Alternative Medicine Market by Type
- 4.3 Therapy
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Therapy Complementary and Alternative Medicine Market by Type
- CHAPTER 5: COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Diabetes
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Cardiovascular
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Neurology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Cancer
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Arthritis
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- 5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country
- CHAPTER 6: COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Direct Sales
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Online Sales
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Distance Correspondence
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Disease Indication
- 7.2.4 North America Market size and forecast, by Distribution Channels
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Disease Indication
- 7.2.5.1.3 Market size and forecast, by Distribution Channels
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Disease Indication
- 7.2.5.2.3 Market size and forecast, by Distribution Channels
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Disease Indication
- 7.2.5.3.3 Market size and forecast, by Distribution Channels
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Disease Indication
- 7.3.4 Europe Market size and forecast, by Distribution Channels
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Disease Indication
- 7.3.5.1.3 Market size and forecast, by Distribution Channels
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Disease Indication
- 7.3.5.2.3 Market size and forecast, by Distribution Channels
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Disease Indication
- 7.3.5.3.3 Market size and forecast, by Distribution Channels
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Disease Indication
- 7.3.5.4.3 Market size and forecast, by Distribution Channels
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Disease Indication
- 7.3.5.5.3 Market size and forecast, by Distribution Channels
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Disease Indication
- 7.3.5.6.3 Market size and forecast, by Distribution Channels
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Disease Indication
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channels
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Disease Indication
- 7.4.5.1.3 Market size and forecast, by Distribution Channels
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Disease Indication
- 7.4.5.2.3 Market size and forecast, by Distribution Channels
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Disease Indication
- 7.4.5.3.3 Market size and forecast, by Distribution Channels
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Disease Indication
- 7.4.5.4.3 Market size and forecast, by Distribution Channels
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Disease Indication
- 7.4.5.5.3 Market size and forecast, by Distribution Channels
- 7.4.5.6 Rest Of Asia Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Disease Indication
- 7.4.5.6.3 Market size and forecast, by Distribution Channels
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Disease Indication
- 7.5.4 LAMEA Market size and forecast, by Distribution Channels
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Disease Indication
- 7.5.5.1.3 Market size and forecast, by Distribution Channels
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Disease Indication
- 7.5.5.2.3 Market size and forecast, by Distribution Channels
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Disease Indication
- 7.5.5.3.3 Market size and forecast, by Distribution Channels
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Disease Indication
- 7.5.5.4.3 Market size and forecast, by Distribution Channels
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Columbia Nutritional
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Herb Pharm
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Herbal Hills
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Helio USA Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 NatureKue
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Nordic Nutraceuticals
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Pure encapsulations, LLC.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 The Healing Company Ltd.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 AYUSH Ayurvedic Pte Ltd.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Sheng Chang Pharmaceutical Company
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Bikram Yoga
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Amrita Ayurveda and Yoga
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Body and Soul Yoga Club
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 ALCES LLP
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Yoga Tree Studios, Inc.
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 LKK Health Products Group Limited
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR MEDICINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR MEDICINES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL MEDICINES COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR THERAPY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 7. GLOBAL THERAPY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 9. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR DIABETES, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR DIABETES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR CARDIOVASCULAR, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR CARDIOVASCULAR, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR CANCER, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR CANCER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR ARTHRITIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR ARTHRITIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. GLOBAL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 22. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR DIRECT SALES, BY REGION, 2021-2031 ($MILLION)
- TABLE 23. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR DIRECT SALES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR ONLINE SALES, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR ONLINE SALES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SIZE, FOR DISTANCE CORRESPONDENCE, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET FOR DISTANCE CORRESPONDENCE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. NORTH AMERICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 33. U.S. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 34. U.S. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 35. U.S. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 36. CANADA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 37. CANADA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 38. CANADA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 39. MEXICO COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 40. MEXICO COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 41. MEXICO COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 42. EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 43. EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 44. EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 45. EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 46. GERMANY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 47. GERMANY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 48. GERMANY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 49. FRANCE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. FRANCE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 51. FRANCE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 52. UK COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 53. UK COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 54. UK COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 55. ITALY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 56. ITALY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 57. ITALY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 58. SPAIN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 59. SPAIN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 60. SPAIN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 61. REST OF EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 62. REST OF EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 63. REST OF EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 64. ASIA-PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 68. JAPAN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. JAPAN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 70. JAPAN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 71. CHINA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. CHINA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 73. CHINA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 74. AUSTRALIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. AUSTRALIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 76. AUSTRALIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 77. INDIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 78. INDIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 79. INDIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 80. SOUTH KOREA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 81. SOUTH KOREA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 82. SOUTH KOREA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 83. REST OF ASIA PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 84. REST OF ASIA PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 85. REST OF ASIA PACIFIC COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 86. LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 87. LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 88. LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 89. LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 90. BRAZIL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 91. BRAZIL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 92. BRAZIL COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 93. SAUDI ARABIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 94. SAUDI ARABIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 95. SAUDI ARABIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 96. SOUTH AFRICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 97. SOUTH AFRICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 98. SOUTH AFRICA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 99. REST OF LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 100. REST OF LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISEASE INDICATION, 2021-2031 ($MILLION)
- TABLE 101. REST OF LAMEA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET, BY DISTRIBUTION CHANNELS, 2021-2031 ($MILLION)
- TABLE 102.COLUMBIA NUTRITIONAL: COMPANY SNAPSHOT
- TABLE 103.COLUMBIA NUTRITIONAL: OPERATING SEGMENTS
- TABLE 104.COLUMBIA NUTRITIONAL: PRODUCT PORTFOLIO
- TABLE 105.COLUMBIA NUTRITIONAL: NET SALES,
- TABLE 106.COLUMBIA NUTRITIONAL: KEY STRATERGIES
- TABLE 107.HERB PHARM: COMPANY SNAPSHOT
- TABLE 108.HERB PHARM: OPERATING SEGMENTS
- TABLE 109.HERB PHARM: PRODUCT PORTFOLIO
- TABLE 110.HERB PHARM: NET SALES,
- TABLE 111.HERB PHARM: KEY STRATERGIES
- TABLE 112.HERBAL HILLS: COMPANY SNAPSHOT
- TABLE 113.HERBAL HILLS: OPERATING SEGMENTS
- TABLE 114.HERBAL HILLS: PRODUCT PORTFOLIO
- TABLE 115.HERBAL HILLS: NET SALES,
- TABLE 116.HERBAL HILLS: KEY STRATERGIES
- TABLE 117.HELIO USA INC.: COMPANY SNAPSHOT
- TABLE 118.HELIO USA INC.: OPERATING SEGMENTS
- TABLE 119.HELIO USA INC.: PRODUCT PORTFOLIO
- TABLE 120.HELIO USA INC.: NET SALES,
- TABLE 121.HELIO USA INC.: KEY STRATERGIES
- TABLE 122.NATUREKUE: COMPANY SNAPSHOT
- TABLE 123.NATUREKUE: OPERATING SEGMENTS
- TABLE 124.NATUREKUE: PRODUCT PORTFOLIO
- TABLE 125.NATUREKUE: NET SALES,
- TABLE 126.NATUREKUE: KEY STRATERGIES
- TABLE 127.NORDIC NUTRACEUTICALS: COMPANY SNAPSHOT
- TABLE 128.NORDIC NUTRACEUTICALS: OPERATING SEGMENTS
- TABLE 129.NORDIC NUTRACEUTICALS: PRODUCT PORTFOLIO
- TABLE 130.NORDIC NUTRACEUTICALS: NET SALES,
- TABLE 131.NORDIC NUTRACEUTICALS: KEY STRATERGIES
- TABLE 132.PURE ENCAPSULATIONS, LLC.: COMPANY SNAPSHOT
- TABLE 133.PURE ENCAPSULATIONS, LLC.: OPERATING SEGMENTS
- TABLE 134.PURE ENCAPSULATIONS, LLC.: PRODUCT PORTFOLIO
- TABLE 135.PURE ENCAPSULATIONS, LLC.: NET SALES,
- TABLE 136.PURE ENCAPSULATIONS, LLC.: KEY STRATERGIES
- TABLE 137.THE HEALING COMPANY LTD.: COMPANY SNAPSHOT
- TABLE 138.THE HEALING COMPANY LTD.: OPERATING SEGMENTS
- TABLE 139.THE HEALING COMPANY LTD.: PRODUCT PORTFOLIO
- TABLE 140.THE HEALING COMPANY LTD.: NET SALES,
- TABLE 141.THE HEALING COMPANY LTD.: KEY STRATERGIES
- TABLE 142.AYUSH AYURVEDIC PTE LTD.: COMPANY SNAPSHOT
- TABLE 143.AYUSH AYURVEDIC PTE LTD.: OPERATING SEGMENTS
- TABLE 144.AYUSH AYURVEDIC PTE LTD.: PRODUCT PORTFOLIO
- TABLE 145.AYUSH AYURVEDIC PTE LTD.: NET SALES,
- TABLE 146.AYUSH AYURVEDIC PTE LTD.: KEY STRATERGIES
- TABLE 147.SHENG CHANG PHARMACEUTICAL COMPANY: COMPANY SNAPSHOT
- TABLE 148.SHENG CHANG PHARMACEUTICAL COMPANY: OPERATING SEGMENTS
- TABLE 149.SHENG CHANG PHARMACEUTICAL COMPANY: PRODUCT PORTFOLIO
- TABLE 150.SHENG CHANG PHARMACEUTICAL COMPANY: NET SALES,
- TABLE 151.SHENG CHANG PHARMACEUTICAL COMPANY: KEY STRATERGIES
- TABLE 152.BIKRAM YOGA: COMPANY SNAPSHOT
- TABLE 153.BIKRAM YOGA: OPERATING SEGMENTS
- TABLE 154.BIKRAM YOGA: PRODUCT PORTFOLIO
- TABLE 155.BIKRAM YOGA: NET SALES,
- TABLE 156.BIKRAM YOGA: KEY STRATERGIES
- TABLE 157.AMRITA AYURVEDA AND YOGA: COMPANY SNAPSHOT
- TABLE 158.AMRITA AYURVEDA AND YOGA: OPERATING SEGMENTS
- TABLE 159.AMRITA AYURVEDA AND YOGA: PRODUCT PORTFOLIO
- TABLE 160.AMRITA AYURVEDA AND YOGA: NET SALES,
- TABLE 161.AMRITA AYURVEDA AND YOGA: KEY STRATERGIES
- TABLE 162.BODY AND SOUL YOGA CLUB: COMPANY SNAPSHOT
- TABLE 163.BODY AND SOUL YOGA CLUB: OPERATING SEGMENTS
- TABLE 164.BODY AND SOUL YOGA CLUB: PRODUCT PORTFOLIO
- TABLE 165.BODY AND SOUL YOGA CLUB: NET SALES,
- TABLE 166.BODY AND SOUL YOGA CLUB: KEY STRATERGIES
- TABLE 167.ALCES LLP: COMPANY SNAPSHOT
- TABLE 168.ALCES LLP: OPERATING SEGMENTS
- TABLE 169.ALCES LLP: PRODUCT PORTFOLIO
- TABLE 170.ALCES LLP: NET SALES,
- TABLE 171.ALCES LLP: KEY STRATERGIES
- TABLE 172.YOGA TREE STUDIOS, INC.: COMPANY SNAPSHOT
- TABLE 173.YOGA TREE STUDIOS, INC.: OPERATING SEGMENTS
- TABLE 174.YOGA TREE STUDIOS, INC.: PRODUCT PORTFOLIO
- TABLE 175.YOGA TREE STUDIOS, INC.: NET SALES,
- TABLE 176.YOGA TREE STUDIOS, INC.: KEY STRATERGIES
- TABLE 177.LKK HEALTH PRODUCTS GROUP LIMITED: COMPANY SNAPSHOT
- TABLE 178.LKK HEALTH PRODUCTS GROUP LIMITED: OPERATING SEGMENTS
- TABLE 179.LKK HEALTH PRODUCTS GROUP LIMITED: PRODUCT PORTFOLIO
- TABLE 180.LKK HEALTH PRODUCTS GROUP LIMITED: NET SALES,
- TABLE 181.LKK HEALTH PRODUCTS GROUP LIMITED: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET SEGMENTATION
- FIGURE 2.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031
- FIGURE 3.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MEDICINES COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF THERAPY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 15.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,BY DISEASE INDICATION,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIABETES COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CANCER COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ARTHRITIS COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 22.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,BY DISTRIBUTION CHANNELS,2021(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DIRECT SALES COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE SALES COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DISTANCE CORRESPONDENCE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031(%)
- FIGURE 26.COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET BY REGION,2021
- FIGURE 27.U.S. COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 28.CANADA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 29.MEXICO COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 30.GERMANY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 31.FRANCE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 32.UK COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 33.ITALY COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 34.SPAIN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 35.REST OF EUROPE COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 37.CHINA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 38.AUSTRALIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGURE 39.INDIA COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET,2021-2031($MILLION)
- FIGUR
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook